Lisdexamfetamine Dimesylate Capsules
Pre-Solicitation Posted
Not the latest version. See the latest solicitation from .
- Solicitation number
- SPE2D2-26-R-0004
- Agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Responses due
- Not on record
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The Defense Logistics Agency Troop Support Medical is planning to issue a national requirements contract for Lisdexamfetamine Dimesylate Capsules in various strengths (10 MG through 70 MG) and package sizes (90-count and 100-count bottles). This is an unrestricted, fully competitive acquisition classified as a commercial item and will be solicited using FAR Part 12 procedures. The contract will be firm-fixed price with a one-year base period and four one-year options, establishing a national supply source for procurement by the Department of Defense, Indian Health Service, and Department of Veterans Affairs through DLA and VA prime vendor programs. The solicitation will be posted to both the DLA Bid Board System (DIBBS) and SAM.gov, with interested parties directed to contact Courtney Hunter at (445) 737-3585 or Courtney.Hunter@dla.mil for questions. The projected solicitation date is March 2026, though the DLA reserves the right to issue it before or after that timeframe. All sources are eligible to submit proposals for consideration.
No set-aside designations have been applied to this procurement opportunity. While specific award values and annual usage estimates are not detailed in this pre-solicitation notice, the Schedule of Supplies section of the forthcoming solicitation will provide annual usage estimates to inform pricing considerations. The contract's scope encompasses seven dosage strengths available in both 90-count and 100-count bottle configurations, supporting a multi-agency customer base across defense and veterans healthcare systems. Interested parties are advised to establish automated notifications through SAM.gov to remain informed of any changes to the pre-solicitation notice or the final solicitation timeline, as the DLA retains flexibility in the actual release date.
Notice text
The Defense Logistics Agency is planning to issue a solicitation for a national requirements contract for Lisdexamfetamine Dimesylate Capsules. Procurement details follow.
Lisdexamfetamine Dimesylate: 10 MG, 20 MG, 30 MG, 40 MG, 50 MG, 60 MG, and 70 MG Capsules in 90 Count Bottles and 10 MG, 20 MG, 30 MG, 40 MG, 50 MG, 60 MG, and 70 MG Capsules in 100 Count Bottles. This will be an unrestricted and fully competitive acquisition. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. A contract resulting from this solicitation will establish a national supply source, in accordance with FAR 52.216-21 (Requirements), to provide the items listed in the schedule for purchase by Department of Defense, Indian Health Service, and Department of Veterans Affairs customers through the DLA and VA prime vendor programs. The annual usage estimates will be provided in the Schedule of Supplies section of the solicitation. This is a commercial item and will be solicited using FAR part 12. All sources may submit a proposal which shall be considered by the agency.
A copy of the solicitation will be posted to the DLA Bid Board System (DIBBS) at https://www.dibbs.bsm.dla.mil and SAM.gov at https://sam.gov. Interested parties should contact Courtney Hunter at (445) 737-3585 or Courtney.Hunter@dla.mil for any questions/comments. Interested parties are further advised to set up automated notifications of pre-solicitation or solicitation changes through this website. The current projected solicitation date is March of 2026. DLA reserves the right to issue the solicitation before or after the projected solicitation date.
Notice history
| Notice | Type | Posted |
|---|---|---|
| Lisdexamfetamine Dimesylate Capsules Solicitation | Solicitation | |
| This notice | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Methylphenidate ER | Medical Supply Chain | No set-aside | |
| Epinephrine Injector | Medical Supply Chain | No set-aside | |
| 6505--Imatinib Tablets | National Acquisition Center | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity